Early Ultrasound Evaluation Identifies Excellent Responders to Neoadjuvant Systemic Therapy in Patients with Triple Negative Breast Cancer

BACKGROUND: Heterogeneity exists in triple negative breast cancer (TNBC) response to standard anthracycline/taxane based neoadjuvant systemic therapy (NAST) with 40–50% of patients having pathologic complete response to therapy (pCR). Early assessment of imaging response during NAST may identify a s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Adrada, Beatriz E., Candelaria, Rosalind, Moulder, Stacy, Thompson, Alastair, Wei, Peng, Whitman, Gary J., Valero, Vicente, Litton, Jennifer K., Santiago, Lumarie, Scoggins, Marion E., Moseley, Tanya, White, Jason B, Ravenberg, Elizabeth. E, Yang, Wei T., Rauch, Gaiane M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8319084/
https://ncbi.nlm.nih.gov/pubmed/33878210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33604
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados